Tauroursodeoxycholate (Standard)

CAT:
804-HY-19696R-01
Size:
5 mg

For Laboratory Research Only. Not for Clinical or Personal Use.

  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Tauroursodeoxycholate (Standard) - image 1

Tauroursodeoxycholate (Standard)

  • Description:

    Tauroursodeoxycholate (Standard) is the analytical standard of Tauroursodeoxycholate. This product is intended for research and analytical applications. Tauroursodeoxycholate (Tauroursodeoxycholic acid) is an endoplasmic reticulum (ER) stress inhibitor. Tauroursodeoxycholate significantly reduces expression of apoptosis molecules, such as caspase-3 and caspase-12. Tauroursodeoxycholate also inhibits ERK.
  • Product Name Alternative:

    Tauroursodeoxycholic acid (Standard) ; TUDCA (Standard) ; UR 906 (Standard)
  • UNSPSC:

    12352211
  • Hazard Statement:

    H302, H315, H319, H335
  • Target:

    Apoptosis; Caspase; Endogenous Metabolite; ERK; Reference Standards
  • Type:

    Reference Standards
  • Related Pathways:

    Apoptosis; MAPK/ERK Pathway; Metabolic Enzyme/Protease; Others; Stem Cell/Wnt
  • Field of Research:

    Cancer
  • Assay Protocol:

    https://www.medchemexpress.com/tauroursodeoxycholate-standard.html
  • Purity:

    99.77
  • Smiles:

    C[C@H](CCC(NCCS(=O)(O)=O)=O)[C@H]1CC[C@@]2([H])[C@]3([H])[C@@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C
  • Molecular Formula:

    C26H45NO6S
  • Molecular Weight:

    499.70
  • Precautions:

    H302, H315, H319, H335
  • References & Citations:

    [1]Kim SY, et al. Tauroursodeoxycholate (TUDCA) inhibits neointimal hyperplasia by suppression of ERK viaPKCα-mediated MKP-1 induction. Cardiovasc Res. 2011 Nov 1;92 (2) :307-16.|[2]Qin Y, et al. Tauroursodeoxycholic Acid Attenuates Angiotensin II Induced Abdominal Aortic Aneurysm Formation in Apolipoprotein E-deficient Mice by Inhibiting Endoplasmic Reticulum Stress. Eur J Vasc Endovasc Surg. 2017 Mar;53 (3) :337-345.|[3]Kim SY, et al. Tauroursodeoxycholate (TUDCA) inhibits neointimal hyperplasia by suppression of ERK viaPKCα-mediated MKP-1 induction. Cardiovasc Res. 2011 Nov 1;92 (2) :307-16.|[4]Qin Y, et al. Tauroursodeoxycholic Acid Attenuates Angiotensin II Induced Abdominal Aortic Aneurysm Formation in Apolipoprotein E-deficient Mice by Inhibiting Endoplasmic Reticulum Stress. Eur J Vasc Endovasc Surg. 2017 Mar;53 (3) :337-345.
  • Shipping Conditions:

    Blue Ice
  • Storage Conditions:

    4°C, sealed storage, away from light and moisture
  • Scientific Category:

    Reference Standards
  • CAS Number:

    [14605-22-2]